Kim Shontz
Nationwide Children's Hospital(US)
Publications by Year
Research Areas
Muscle Physiology and Disorders, Biotin and Related Studies, Virus-based gene therapy research, Cardiomyopathy and Myosin Studies, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → Eteplirsen for the treatment of Duchenne muscular dystrophy(2013)778 cited
- → A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy(2014)229 cited
- → Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes(2017)104 cited
- → AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models(2015)96 cited
- → Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice(2008)90 cited
- → Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice(2017)40 cited
- Eteplirsen for the treatment of duchenne muscular dystrophy. Ann Neurol(2013)
- → Eteplirsen, a phosphorodiamidate morpholino oligomer (PMO) for Duchenne muscular dystrophy (DMD): Longitudinal comparison to external controls on six-minute walk test (6MWT) and loss of ambulation (LOA)(2016)2 cited
- → G.P.110(2014)2 cited
- → Eteplirsen, a Phosphorodiamidate Morpholino Oligomer (PMO) for Duchenne Muscular Dystrophy (DMD): Clinical Update and Longitudinal Comparison to External Controls on Six-Minute Walk Test (6MWT) (S28.001)(2016)1 cited